Babyscripts Announces Strategic Partnership with Penn Medicine to Improve Postpartum Health

WASHINGTON, Feb. 26, 2019 /PRNewswire-PRWeb/ -- Babyscripts, Inc., the leading virtual care platform for managing obstetrics, announced today that they are entering into a strategic partnership with Penn Medicine, one of the world's leading academic medical centers, to improve postpartum health. This partnership will pair Babyscripts' remote monitoring technology with the knowledge gained from Penn Medicine's Heart Safe Motherhood program (HSM) to improve the quality of postpartum care while lowering costs.

The partnership will develop a solution that enables the remote monitoring of hypertensive patients to identify those who need additional attention, as well increase the number of blood pressure readings in the postpartum stage to catch and act on rising blood pressure earlier, decrease the length of hospital stay, and decrease readmissions following delivery.

Penn Medicine is uniquely positioned to support Babyscripts' expansion into the postpartum space with HSM, their novel approach to care delivery for women with pregnancy-related hypertension that leverages connected health technology to transform the quality, safety, experience, and cost of care during women's transition from hospital admission after delivery to home.

In 2018, Adi Hirshberg, MD, an assistant professor of Obstetrics and Gynecology at Penn Medicine, and Sindhu Srinivas, MD, director of Obstetrical Services at the Hospital of the University of Pennsylvania, published a randomized controlled trial comparing traditional office-based follow-up with HSM, a remote text-based blood pressure monitoring program in the postpartum period immediately after hospital discharge. They demonstrated an increase in blood pressure data captured within 10 days after hospital discharge (44 percent vs. 92 percent), a significant reduction in 7 day readmissions (4 percent vs. 0 percent) for postpartum hypertension, and a significant increase in postpartum visit attendance (58 percent vs. 69 percent).
Babyscripts will focus on taking the care protocols and program elements tested through Penn Medicine's HSM and translate those accomplishments onto the Babyscripts platform for postpartum monitoring in women with pregnancy related hypertension.

"We are incredibly excited to partner with Penn Medicine to improve the management of patients after they deliver," says Juan Pablo Segura, President and co-founder of Babyscripts. "This is another example of what Babyscripts uniquely brings to the table. For us, it's not just technology tools. It's protocols and best practices that have proven success. Our goal is completely redefining maternal care, this is another huge step towards eliminating complications."

"We are very proud of the work we have done with HSM and the results we have been able to achieve at two of our Penn Medicine hospitals. We are eager to partner with Babyscripts to build on our experience to improve health outcomes for mothers," says Srinivas. "Postpartum hypertension is a critical area of concern in maternal health, and we are excited to see Babyscripts use our research and their technology to scale a solution."

Babyscripts has spent the last four years building a clinically validated, virtual care platform to allow OBGYNs to deliver a new model of prenatal care. Using internet-connected devices for remote monitoring, Babyscripts offers risk-specific experiences to allow providers to manage up to 90% of pregnancies virtually, allowing doctors to detect risk more quickly and automate elements of care.

About Babyscripts
Babyscripts(TM) is a new model for prenatal and postpartum care that is transforming the way expectant mothers use technology to work with their OBGYN practice. It's the first mobile, clinical solution to provide remote monitoring of an obstetrician's patient population while directly improving patient satisfaction and practice reimbursement.

SOURCE Babyscripts